Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × taxane × Clear all

NCT00044551 2013-10-14

Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Non-Hodgkin